A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)

Recruiting

Phase 2

BRTX 100A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)

Sponsor:

BioRestorative Therapies

Code:

NCT04042844

Conditions

Lumbar Disc Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BRTX-100

Saline

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-17. This information was provided to ClinicalTrials.gov by BioRestorative Therapies on 2025-08-26.